Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
... the tumor are reduced or delayed. The primary and
secondary endpoints of the denosumab bone metastases ... cancer) or multiple myeloma and bone metastases.
secondary endpoints were to evaluate if denosumab is ... number of patients developing metastatic disease
secondary to a primary cancer is increasing. Bone ...
Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis
... MAESTRO-01 Phase III trial in patients with
secondary progressive multiple sclerosis (SPMS). In ... differences between dirucotide and placebo on the
secondary endpoints of the study.
The data also ... 30-40 percent of all MS patients have the
secondary progressive form of the disease(vi), in which ...
Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
... with advanced breast cancer met its primary and
secondary endpoints and demonstrated superior efficacy ... tumor are reduced or delayed. The primary and
secondary endpoints of the denosumab bone metastases ... with advanced breast cancer and bone metastases.
secondary endpoints were to evaluate if denosumab was ...
Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
... improvements as compared to placebo in multiple
secondary endpoints associated with cardiovascular risk. ... Center. "Lorcaserin's positive impact on multiple
secondary measures has important implications for improving ... the ITT-LOCF and per protocol populations.
secondary Endpoint Analysis
New data demonstrate that ...
Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry
... improvement versus placebo in both primary and
secondary efficacy assessments at all study visits starting ... BPRSd (-8.9 vs. -4.2; p=0.012), as well as on all
secondary efficacy measures, including the PANSS (Positive ... was the BPRSd extracted from the PANSS. The
secondary efficacy measures included the PANSS total and ...
Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
... of partial onset seizures with or without
secondary generalization in patients with epilepsy age 16 ... uncontrolled seizures or significant side effects
secondary to medication. This highlights the ongoing need ... of partial-onset seizures with or without
secondary generalisation in patients with epilepsy aged 16 ...
Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
... significance in CAPACITY 2 (p=0.001). The
secondary endpoints of progression-free survival (PFS) and ... endpoint of change in percent predicted FVC and
secondary endpoints of progression-free survival and ... 2, p=0.004 and CAPACITY 1, p=0.001).
secondary Efficacy Endpoint Results
In CAPACITY 2, ...
Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
... factor of cardiovascular disease (CVD).(1) The
secondary objective of the ROADMAP trial includes incidence ... and mortality. A qualitative parameter in the
secondary objective was to measure cuff blood pressure ... excludes agents that directly block the RAS. The
secondary objective is to test the hypothesis that ...
Anthera's Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
...
- Favorable results for
secondary endpoints support outcomes benefit
HAYWARD, ... positive results for all clinically important
secondary endpoints. The initial data review demonstrated: ... "In addition to meeting the primary and several
secondary endpoints, clinical data from the FRANCIS study ...
Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients With Multiple Sclerosis
... a Significant Reduction in Relapse Rate
-
secondary Endpoints met Including MRI Measures, Proportion ... (AAN) in Seattle, WA.
"All primary and
secondary endpoints of the CLARITY study were statistically ... of patients who remained relapse-free (one
secondary endpoint of the trial) was significantly higher ...
Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
... of experts blinded to the study arm. The
secondary efficacy analyses included time to disease ... significant difference. However, in the
secondary efficacy analysis there were 87 clinical events ... The main events causing the difference on
secondary analysis were emergence or enlargement of varices ...
Schering-Plough Announces Results of the Early ACS Trial
... failed to achieve either the primary or
secondary endpoints of the trial. Significantly higher ... or thrombotic bailout through 96 hours. The
secondary endpoint was death or (re)MI at 30 days. Safety ... between the groups in either the primary or
secondary endpoints. The primary endpoint occurred in 9.3 ...
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
... (TRAP)-induced platelet aggregation inhibition, a
secondary endpoint. Thrombin is the most potent platelet ... of TRA in patients undergoing PCI. A
secondary objective was to assess whether patients treated ...
The Phase III Thrombin Receptor Antagonist in
secondary Prevention of Atherothrombotic Ischemic Events ...
Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
... overall survival and bone-mineral density were
secondary endpoints. Disease-free survival was defined as ... contralateral breast cancer, distant metastasis,
secondary carcinoma and/or death from any cause. ... breast cancer, distant metastasis and/or
secondary carcinoma. Exploratory endpoints included bone ...
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
... mid- to Late-Stage Parkinson's Disease
--
secondary Efficacy Endpoints of the Study Analyzed to Date ... effect on dyskinesias as primary endpoint.
secondary efficacy endpoints of this study were also met, ... in the dopaminergic neurons of the
brain.
secondary symptoms may include high-level cognitive ...
Alexza's AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
... positive top-line results for the primary and
secondary endpoints,"
said James V. Cassella, PhD, Alexza ... 12.9 -
Key
secondary Efficacy Endpoint
A Clinical Global ... completed for each
patient. CGI-I was the key
secondary endpoint of the study. Both the 10 mg
and the 5 ...
Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
... manner to idraparinux (i.e., bioequipotency). The
secondary objective of the study was occurrence of ... which might be indicative of hepatic toxicity.
secondary endpoints included major adverse cardiovascular ... were no significant differences in the rates of
secondary endpoints.
Once-Daily Oral Rivaroxaban ...
ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%
... surgery. In addition, Xibrom 0.09% QD met the
secondary efficacy endpoint of elimination of ocular pain ... statistical significance in both the primary and
secondary efficacy endpoints. The ER exhibited strong ... eye ("cells") and cellular debris ("flare"). The
secondary efficacy endpoint was evaluated via a pain score ...
NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
... The study
also comfortably met the main
secondary endpoint, demonstrating that
naproxcinod 750 mg ... signs and
symptoms of osteoarthritis.
The main
secondary endpoint of the trial assessed the efficacy ... 750 mg bid comfortably met the
secondary endpoint of being
statistically non-inferior to ...
n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
... * hospital for cardiovascular reasons
secondary endpoint n-3 PUFAs vs ... Accordingly, current
indications of n-3 PUFAs are
secondary prevention in post-myocardial
infarction patients ... in Europe and some Middle East
countries for
secondary prevention of myocardial infarction (MI) ...
Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
... clinical
assessment by health care providers of
secondary lymphedema of the arm in
women.
About ... assess patients early for the potential
onset of
secondary lymphedema. Pre-operative clinical assessment in ... clinical assessment, by health care
providers, of
secondary lymphedema of the arm in women. For ...
Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
... results of the study, including
secondary efficacy endpoints
and safety data, will be ... Patients included in the trial had primary or
secondary MDS with or
without previous therapy with growth ... study
of Dacogen in 99 patients with de novo or
secondary MDS. Dacogen was
administered daily for five days ...
SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
... results of the study, including
secondary efficacy endpoints
and safety data, will be ... Patients included in the trial had primary or
secondary MDS, with or
without previous therapy with growth ... treated and untreated, de novo and
secondary MDS of all
French-American-British (FAB) subtypes ...
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
... addition to the primary endpoint, there were 26
secondary endpoints
that were measured, each of which was ... significance.
The Company believes two important
secondary endpoints are the difference
between the pre- and ... the filing of the BLA; the
importance of certain
secondary endpoints in the CORD I trial, including
the ...
QRxPharma Releases Additional Phase 3 Data for Q8003IR 'Dual Opioid' Pain Therapy
... Efficacy and Tolerability; Study
Goals and
secondary Endpoints Met
SYDNEY, Australia and BEDMINSTER, ... and establish the preferred dose
parameters.
secondary endpoints included: (1) efficacy relating to the ... completed a Phase 3 study and met
primary and
secondary endpoints. The Company's preclinical and ...
Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
... the
primary endpoint of pain, as well as
secondary endpoints of urgency,
frequency and bloating in ... of asimadoline in all of the following
secondary endpoints: urgency, adequate relief of IBS ... significant benefit was also seen in the
secondary endpoint of adequate relief of IBS ...
Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
... Statistical non-inferiority to TAXUS in the major
secondary (co-primary) endpoint of target vessel ... 43 percent reduction in the pre-specified
secondary endpoint of major adverse cardiac events ... late loss at eight
months and the major
secondary (co-primary) endpoint was TVF at nine
months. An ...
Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimer's Disease Announced
... month data will
be available later this year.
secondary endpoint results suggest that levels of ... building
blocks of Alzheimer's.
The primary and
secondary endpoint data were reported by the ... of Change (ADCS-CGIC) change
rating). The
secondary endpoints measured changes in beta-amyloid ...
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
... and older with
pharyngitis and/or tonsillitis
secondary to Streptococcus pyogenes
(commonly referred to ... to the comparator therapy
in all primary and
secondary endpoints.
Important Safety Information
... the treatment of tonsillitis and/or
pharyngitis
secondary to Streptococcus pyogenes in adults and ...
Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
... were males with a
diagnosis of either primary or
secondary hypogonadism, a body weight >65
kg, and at least ... a concentration
of 1500 ng/dL.
In addition,
secondary outcomes included measurements evaluating ... improvements from baseline in the key
secondary clinical
outcome variables.
NEBIDO was ...
NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
... of inhaled TPI 1020 in COPD
patients. A
secondary outcome will also measure the change in ... of neutrophils in the lungs. Additional
secondary outcome measures will follow the effect of ... neutrophil counts between baseline and day 42. A
secondary endpoint
will also measure the change in sputum ...
SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
... an additional 60 days post-treatment. A
secondary endpoint in a sub-study within the primary ... The Phase III Thrombin Receptor Antagonist in
secondary Prevention of
Atherothrombotic Ischemic Events ... coronary revascularization or stroke.
The key
secondary endpoint is the composite of cardiovascular ...
CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
... endpoints of
the study were objective response.
secondary endpoints included stable
disease rate, survival, ... and
pharmacokinetics of oral belinostat.
secondary objectives include
assessment of the ... or for which no
standard treatment exists.
secondary endpoints included pharmacokinetics
(PK), ...
R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
... doses under fasting conditions. The
secondary objective of Part 1
is to explore the effect of ... or
twice- daily (BID) dosing for 14 days. The
secondary objective is to assess
antiviral activity by ... in
combination with Pegasys plus Copegus. The
secondary objective of Part 3 is
to evaluate the short-term ...
Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
... statistical
significance, improvement in key
secondary measures at 40 mg, nevertheless,
were either ... for the primary endpoint
of the study. These key
secondary measures included nausea or ... headache pain response at two hours
post-dose.
secondary efficacy endpoints included the traditional ...
New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
... -- Post-hoc and other
analyses of
secondary endpoints of a long-term safety and ... active, mild to moderate UC. Post-hoc
analysis of
secondary endpoints provided evidence that LIALDA ... Exhibit Hall B, #950 A post-hoc analysis of
secondary endpoints from the long-term 303 study
was ...
Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
... doses under fasting conditions. The
secondary objective of Part 1
is to explore the effect of ... or
twice- daily (BID) dosing for 14 days. The
secondary objective is to assess
antiviral activity by ... in
combination with Pegasys plus Copegus. The
secondary objective of Part 3 is
to evaluate the short-term ...
Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
... doses under fasting conditions. The
secondary objective of this
study was to explore the effect ... ascending doses under fasting conditions. The
secondary objective of Part 1 is to explore the effect ... once-daily or twice-daily dosing for 14 days. The
secondary objective is to assess antiviral activity by ...
NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
... Trial Meets Primary and All
secondary Endpoints
San Carlos, Calif., Sept. 4 ... were achieved for study weeks 2-12
(p<0.02), a
secondary endpoint. All other
secondary endpoints, including
30% and 50% responder ...
Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
... has successfully met its primary and
secondary endpoints,
demonstrating positive results in ... the G-CSF/placebo group to reach this
threshold.
secondary outcomes were consistent with the primary ... two million cells collected in
four days. Other
secondary outcomes were also supportive, including the ...